| |
Representative
publications |
1. Bartalena L, Bogazzi F, Tanda ML, Manetti L, Dell’Unto E,
Martino E:Cigarette smoking and the thyroid. Eur J Endocrinol 133:
507, 1995
2. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell’Unto
E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino
E, Pinchera A: Relation between therapy for hyperthyroidism and the
course of Graves’ ophthalmopathy.N Engl J Med 338 (2) : 73-78,1998
3. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell’Unto E,
Bartolomei MP, Nardi M, Martino E, Pinchera A:Cigarette smoking and
treatment outcomes in Graves’ ophthalmopathy.Ann Intern Med
129 (8): 632-635,1998
4. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell’Unto E,
Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F,
Nardi M, Pinchera A: Comparison of effectiveness and tolerability
of intravenous or oral glucocorticoids associated with orbital radiotherapy
in the management of severe Graves’ ophthalmopathy: results
of a prospective, single-blind, randomized study: J Clin Endocr Metab
86 (8): 3562-3567, 2001
5. Bogazzi F, Aghini-Lombardi F, Cosci C, Lupi I, Santini F, Tanda
ML, Miccoli P, Basolo F, Pinchera A, Bartalena L, Braverman LE, Martino
E: Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis
prior thyroidectomy. J Endocrinol Invest 25, 176-180, 2002
6. Bartalena L, Marcocci C, Tanda ML, Pinchera A: Management of thyroid
eye disease: Eur J Nucl Med , 29(suppl.2):S458-S465, 2002
7. Bartalena L, Tanda ML, Piantanida E, Lai A: Oxidative stress and
Graves’ ophthalmopathy: in vitro studies and therapeutic implications.
Biofactors 19: 155, 2003.
8. Bartalena L, Tanda ML, Piantanida E, Lai A: The role of somatostatin
analogs in the management of Graves’ ophthalmopathy. J Endocrinol
Invest 26: 109, 2003.
9. Bartalena L, Tanda ML, Piantanida E, Lai A,
Pinchera A: Relationship between management of hyperthyroidism and
course of ophthalmopathy. J Endocrinol Invest 27: 288, 2004.
10. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E,
Lai A, Martino E: Diagnosis and management of amiodarone-induced thyrotoxicosis
in Europe: results of an international survey among members of the
European Thyroid Association. Clin Endocrinol 61: 494, 2004.
11. Bartalena L, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino
E: An uptade on the pharmacological management of hyperthyroidism
due to Graves’ disease. Exp Opin Pharmacother 6: 851, 2005.
12. Bartalena L, Tanda ML, Piantanida E, Lai A: Glucocorticoids and
outcome of radioiodine therapy for Graves’ hyperthyroidism.
Eur J Endocrinol 153: 13, 2005.
13. Dionigi GL, Bacuzzi A, Boni L, Rovera F, Piantanida E, Tanda ML,
Diurni M, Carcano G, Bartalena L, Cuffari S, Dionigi R: Influence
of new technologies on thyroid surgery: state of the art. Expert Rev
Med Devices 2: 547, 2005. |
